Baylor Research Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Baylor Research Institute sits in the top decile of US sponsors by registered trial count (#167 of 15,742 sponsors by registered trial count).
Baylor Research Institute: 180 sponsored US clinical trials, 31 recruiting.
Baylor Research Institute sponsors 180 registered US clinical trials on ClinicalTrials.gov, 31 of them currently recruiting, and 103 completed. 13 of these trials are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 5 trials.
Top-decile sponsor footprint
Baylor Research Institute ranks in the top decile of sponsors by registered trial count (#167 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
103 of 125 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
180 total, page 1 of 4
CALM Study: Cardiomems Assisted Lvad Management
NCT07096544
Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
NCT07353905
Robotic Exoskeletons in Acute Care Therapy
NCT07353892
Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing
NCT06896903
Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino
NCT06517459
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
NCT06348394
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
NCT06569121
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
NCT06517212
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
NCT07217483
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
NCT06008275
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
NCT06829914
Early Robotic Gait Training After Stroke
NCT06430632
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
NCT06210711
Prospective Long-Term Outcomes of a Standardized Ross Procedure
NCT06352671
Expanded Population Health Model Evaluation
NCT06044831
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR
NCT05862558
Dosing of Overground Robotic Gait Training with Functional Outcomes and Neuroplasticity After Spinal Cord Injury
NCT05218447
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke
NCT04534556
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
NCT04926467
Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric Bypass
NCT04901429
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
NCT04664192
COLON-MD: Colon Cancer Longitudinal Study
NCT04751448
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
NCT04265872
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
NCT05371756
Foregut Leaks-Role of Microbiome
NCT07424469
Cardiopulmonary Stress Testing (CPET) AlloSure Study
NCT04656080
The Hepatitis C Transplant Collaborative
NCT04493385
Alirocumab in Patients on a Stable Dialysis Regimen
NCT03480568
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
NCT03383419
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
NCT01904851
Analysis of Graft Function Following Autologous Islet Transplantation
NCT03097185
Connect Qualitative Interviews
NCT07444411
Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator
NCT07526935
Driving Rehabilitation and Innovation for Evaluating Risk in Post-Intensive Care Unit Survivors
NCT05999903
Expanding Delivery of an Evidence-based Weight-loss Intervention to Enhance Access and Reach Underserved Groups After TBI
NCT05699772
Corticosteroid Effect on Achalasia Variant EGJOO
NCT06588348
Continuous Glucose Monitoring of Hospitalized Patients With Diabetes
NCT04230694
Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca
NCT04921904
Targeted Plasticity Therapy for Upper Limb Rehabilitation in Spinal Cord Injuries
NCT04288245
Targeted Plasticity Therapy for Posttraumatic Stress Disorder
NCT04064762
Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA)
NCT03873467
Group Lifestyle Balance™ for Individuals With Traumatic Brain Injury (GLB-TBI)
NCT03594734
Assessing Feasibility of Prolonged Repetitive Near Infrared Light Stimulation in Early to Mid-Stage Dementia
NCT03750409
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
NCT04496362
Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility
NCT02656550
ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes
NCT07460583
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain Injury
NCT07648901
RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)
NCT07605390
Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas
NCT07398456
Skin Subs vs Secondary Intention
NCT07587749
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 14 |
| Phase 3 | 2 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the Baylor Research Institute pipeline
31 recruiting of 180 indexed (17% open); 103 completed (57%).
Phase mix: 13 late (III/IV) vs 33 early (I/II) (early-phase heavy).
Top condition: Stroke (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Baylor Research Institute: open-pipeline peers nationwide
Peers matched on 180 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Baylor Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 180 trials (± recruiting share)
- Abbott · 181 trials · 0% recruiting
- ViiV Healthcare · 182 trials · 4% recruiting
- UConn Health · 178 trials · 11% recruiting
- Fox Chase Cancer Center · 183 trials · 16% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Emory University · 17% recruiting · 1,208 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Baylor Research Institute page
180 registered trials is a research-attention snapshot, not an endorsement of Baylor Research Institute or any single study.
- 31 of Baylor Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Baylor Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Baylor Research Institute pipeline card: 180 registered trials from official public datasets.Report a data error.